Sunday, January 25, 2015

Reasons why 3D Printing Will Control the Medtech Industry

According to Rob Richards, business development manager for Orchid Design (Shelton, CT), which is part of Holt, MI–based orthopedic contract manufacturer Orchid, 3-D printing could soon catch on for manufacturing medical devices. Richards points out that, despite the arguments that one cannot achieve the economies of scale possible through more traditional manufacturing methods, several of devices are not manufactured in the same quantity as in traditional sectors. Besides, some of them exhibit a level of  complexity that would be much more expensive to manufacture through traditional techniques.
Several other  advantages of 3D printing were defended by Richard such as its capacity of being customized, precision and biocompatibility: “The internal geometries and structures are also enabling more biocompatible, porous materials that could allow orthopedic and other implanted devices to have enhanced properties such as promoting bone growth”.
Finally, Richards states that 3D printing is already getting more accurate, faster and cost is getting lower. “It’s only going to get faster and cheaper.”


Sunday, January 11, 2015

Rethinking 2014: Planning 2015

When rethinking about 2014, some consulting companies already have stats that show how the medtech industry performed last year.


            The results show a solid industry, with more than $380 billion worldwide sales, 5% sales growth rate and almost 10% of return on investment.

            As for 2015, the industry in the United States is still adjusting from the new tax on their medical device sales and the European sector is suffering from its internal pressure (see our last blog entry). So it seems like emerging markets are still an attractive type of investment: Asia represents more than one-sixth of the world’s medical device market and one should expect a double-digit growth in markets such as Mexico, Brazil and Malaysia thanks to increasing healthcare spending. “Expect more device companies to focus on these import-heavy markets, with Latin America and the Middle East as the most important growth sources for medical device manufacturers.”